Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130.SZ): Levofloxacin eye drops have obtained a drug registration certificate.
Xidian Pharmaceutical (301130.SZ) published an announcement that the company recently received a notice from the National Medical Products Administration (referred to as "").
Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130.SZ) announced that the company recently received the drug registration certificate for levofloxacin eye drops issued by the National Medical Products Administration (referred to as the "NMPA").
Levofloxacin eye drops are used to treat infectious diseases caused by sensitive bacteria, such as blepharitis, meibomian gland inflammation, dacryocystitis, conjunctivitis, chalazion, keratitis, etc.
Related Articles
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
